Sofamor Danek forges biological spine reconstruction alliance
This article was originally published in Clinica
Executive Summary
Sofamor Danek has agreed to enter a strategic alliance with Genetics Institute in which the two US companies will develop biological products for use in spinal reconstruction. The products will use biopharmaceutical manufacturer Genetics Institute's recombinant human bone morphogenetic protein (rhBMP-2) to induce bone growth in the treatment of spinal disorders.